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Introduction
Endothelial cells lining blood vessels provide a barrier between 
the blood and the tissues. Movement of solutes, nutrients, 
cytokines, and leukocytes across endothelial cells can occur 
through both paracellular and transcellular pathways, in which   
molecules and cells pass either between or through cells, re-
spectively (Engelhardt and Wolburg, 2004; Millán and Ridley, 
2005; Nourshargh and Marelli-Berg, 2005).
Endothelial cell–cell contacts comprise tight and adherens 
junctions similar to those found between adjacent epithelial cells 
but also contain some proteins unique to endothelial cells, includ-
ing vascular endothelial cadherin (VE-cadherin), PECAM-1, 
and ICAM-2 (Dejana et al., 2008). The transmembrane VE-
  cadherin is a key regulator of endothelial barrier function. VE-
cadherin–null mice are embryonic lethal because of defects 
in vascular development (Carmeliet et al., 1999), and VE-
  cadherin–blocking  antibodies  cause  a  dramatic  increase  in   
endothelial permeability in adult mice (Corada et al., 1999).   
In  vitro,  inhibition  of  VE-cadherin  increases  endothelial   
permeability and enhances neutrophil transendothelial migra-
tion (TEM; Hordijk et al., 1999). VE-cadherin dimers link   
adjacent cells via homophilic interactions between their extra-
cellular domains, while associating via their cytoplasmic do-
main with a macromolecular complex that comprises scaffolding 
and adaptor proteins such as - and p120-catenin and plako-
globin (Gumbiner, 2005; Dejana et al., 2008).
Many  different  inflammatory  agents  induce  dynamic 
changes to endothelial junctions to increase movement of   
solutes and leukocytes. Proinflammatory cytokines such as TNF 
and IL-1 induce a gradual increase in vascular permeability, 
which is sustained for many hours after stimulation. In contrast, 
other agents such as histamine or thrombin stimulate acute but 
short-lived changes in permeability. TNF and other inflamma-
tory  mediators  induce  Tyr  phosphorylation  of  VE-cadherin,   
-catenin, and/or p120-catenin (Esser et al., 1998; Shasby et al., 
2002; Hudry-Clergeon et al., 2005; Angelini et al., 2006). Tyr 
phosphorylated VE-cadherin acts as a signaling hub to regulate 
endothelial  barrier  function  by  recruiting  multiple  signaling 
molecules such as Src, Pyk2, PAK (p21-activated kinase), and 
E
ndothelial cell–cell junctions control efflux of small 
molecules and leukocyte transendothelial migra-
tion (TEM) between blood and tissues. Inhibitors of 
phosphoinositide 3-kinases (PI3Ks) increase  endothelial 
barrier function, but the roles of different PI3K isoforms 
have not been addressed. In this study, we determine the 
contribution of each of the four class I PI3K isoforms   
(p110, -, -, and -) to endothelial permeability and 
leukocyte TEM. We find that depletion of p110 but not 
other p110 isoforms decreases TNF-induced endothelial 
permeability, Tyr phosphorylation of the adherens junction 
protein  vascular  endothelial  cadherin  (VE-cadherin),   
and leukocyte TEM. p110 selectively mediates activa-
tion of the Tyr kinase Pyk2 and GTPase Rac1 to regu-
late barrier function. Additionally, p110 mediates the 
association of VE-cadherin with Pyk2, the Rac guanine 
nucleotide exchange factor Tiam-1 and the p85 regula-
tory subunit of PI3K. We propose that p110 regulates 
endothelial barrier function by inducing the forma-
tion of a VE-cadherin–associated protein complex that   
coordinates  changes  to  adherens  junctions  with  the   
actin cytoskeleton.
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Control endothelial cells had a round cobblestone-like 
morphology  with  bundles  of  actin  filaments  predominantly 
around the edges of the cells (Fig. 1 B). VE-cadherin and 
PECAM-1 were localized linearly along cell–cell borders   
(continuous junctions; Fig. 1 B, arrow) and with a broader   
distribution  where  adjacent  cells  overlapped  (overlapping 
junctions;  Fig.  1  B,  arrowheads);  in  these  regions,  VE- 
cadherin often had a unique reticular distribution (Fig. 1 B, 
boxed region in control; and Fig. S2 A; Lampugnani et al., 
1995;  Noria  et  al.,  1999).  As  a  measure  of  overlapping   
junctions, we used VE-cadherin staining to determine the   
junctional area per cell (junctional index; Fig. S2 B). Deple-
tion of p110 but not p110, -, or - increased the level of 
overlapping junctions (Fig. 1, B and C). This was not caused 
by a change in the shape of the cells because neither the spread 
area nor the circularity (circularity = 1 for a circle) were altered 
(Fig. 1, D and E).
p110 regulates endothelial responses  
to TNF
We  have  previously  shown  that TNF  induces  a  progressive 
disruption of endothelial cell junctions and an increase in   
endothelial permeability and stress fibers over 8–24 h after 
stimulation (McKenzie and Ridley, 2007). TNF is also well 
known to induce endothelial elongation (Stolpen et al., 1986). 
Therefore, we investigated whether PI3Ks were activated by 
TNF and whether they affected TNF-induced responses. TNF 
transiently increased PI3K activity, as measured by Akt phos-
phorylation, at 10–30 min, which returned to basal levels at 
60 min. It then gradually increased to 12–18 h (Fig. 2 A). 
This gradual increase correlated well with the time course of 
changes in endothelial cell morphology and cell–cell junctions 
(McKenzie and Ridley, 2007).
Cells treated with TNF for 18 h became elongated, and 
junctions were disrupted, particularly at the ends of elon-
gated cells where VE-cadherin became fragmented (Figs. 2 B 
and 3, A and C; circularity index). p110 depletion inhibited 
cell elongation and increased overlapping adherens junctions 
by over twofold as well as inducing a small increase in cell 
spread area (Figs. 2 B and 3, B and D; junctional index). In 
addition,  the  levels  of  PECAM-1  and  the  tight  junction 
marker ZO-1 were higher at junctions after p110 depletion 
(Figs. 2 B and 3 A). This indicates that junctions are strength-
ened when p110 is inhibited. These changes were not the 
result of altered expression of junctional proteins (Fig. S3 A).   
In contrast to p110 suppression, depletion of p110, -,   
or - did not affect TNF-induced changes to cell–cell junc-
tions or cell shape (Fig. 3, B–D; and Fig. S4, A and B). p110 
depletion did not block all TNF-induced signaling because it 
did not affect early p38MAPK phosphorylation (5–60 min; 
Fig. S3 B). Interestingly, p110 expression increased gradu-
ally over 18 h after TNF addition (Fig. S3 C), which could 
contribute  to  the  progressive  changes  to  endothelial  mor-
phology and junctions.
In  addition  to  alterations  to  cell–cell  junctions  and 
cell shape, TNF induced a dramatic increase in actin stress   
fibers aligned in parallel bundles along the longest axis of the 
Tiam-1 (van Buul et al., 2005; Bäumer et al., 2006; Allingham 
et al., 2007; Turowski et al., 2008). Proinflammatory mediators 
also stimulate changes in cell shape and actin stress fiber re-
organization (Essler et al., 1998; Hordijk et al., 1999), which 
are proposed to aid junctional disruption during paracellular 
TEM by increasing tensile force on cell–cell junctions (Wojciak- 
Stothard and Ridley, 2002; Millán and Ridley, 2005). Several 
signaling pathways have been implicated in these responses,   
including the Rho GTPases Rho and/or Rac, the Rho target 
ROCK (Rho-associated, coiled-coil–containing kinase), Src ki-
nases, and phosphoinositide 3-kinases (PI3Ks; Vouret-Craviari 
et al., 1998; Wójciak-Stothard et al., 1998; Lampugnani et al., 
2002; van Wetering et al., 2003; Birukova et al., 2005; Kilic 
et al., 2006; Birukov, 2009; Hu and Minshall, 2009).
PI3Ks affect multiple steps of the inflammatory process, 
including leukocyte TEM (Carman and Springer, 2004; Puri   
et al., 2004, 2005; Nakhaei-Nejad et al., 2007; Li et al., 2008; 
Serban et al., 2008). Class I (A and B) PI3Ks consist of a 110-kD 
catalytic subunit and a regulatory subunit. Class IA comprises 
three catalytic isoforms, p110, -, and -, bound to one of five 
regulatory  subunits  (p85  and  -,  p55  and  -,  and  p50), 
whereas class IB comprises the p110 catalytic isoform bound   
to either a p101 or p84 regulatory subunit (Suire et al., 2005; 
Cain and Ridley, 2009). Class 1A isoforms are usually activated 
by binding of the regulatory subunit to Tyr phosphorylated pro-
teins, whereas class 1B PI3K is activated by G protein–coupled 
receptors (Vanhaesebroeck et al., 2001). Studies in gene-targeted 
mice have shown that class 1A PI3Ks, particularly p110, are 
important for vascular development and angiogenesis (Graupera   
et al., 2008; Yuan et al., 2008), but whether they regulate endo-
thelial junction integrity has not been studied.
In this study, we investigate the roles of each of the class I 
PI3K isoforms in endothelial barrier function and leukocyte TEM 
using siRNA and identify a key role for p110 in these processes 
through downstream effects on VE-cadherin Tyr phosphorylation, 
the Tyr kinase Pyk2, and the GTPase Rac.
Results
p110 regulates junctional morphology in 
endothelial cells
To investigate the roles of class I PI3K isoforms in regulating   
endothelial junctions, human umbilical vein endothelial cells   
(HUVECs) were transfected with siRNAs targeting p110, 
-, -, or -. Knockdown of each isoform did not affect the   
expression levels of the other isoforms or the regulatory sub-
unit p85 (Fig. 1 A and Fig. S1, A and B). As a readout for PI3K   
activity, we monitored Akt phosphorylation at residues Ser473   
and Thr308 (Vanhaesebroeck and Alessi, 2000; Vanhaesebroeck   
et al., 2001). Knockdown of p110, -, and - significantly   
reduced Akt phosphorylation (Fig. 1 A and Fig. S1 C). The 
strongest reduction was observed after p110 depletion, which   
is  consistent  with  observations  in  VEGF-stimulated  mouse   
endothelial cells (Graupera et al., 2008), whereas p110 siRNA 
only had a small effect on total Akt phosphorylation, reflect-
ing the very low levels of this isoform in endothelial cells 
(Graupera et al., 2008).865 p110 regulates endothelial barrier function • Cain et al.
Figure 1.  Inhibition of p110 increases junctional overlap in endothelial cells. (A) p110 siRNA–transfected HUVECs were lysed and analyzed by SDS-
PAGE and blotting for PI3K subunits and Akt phosphorylation. siRNA oligonucleotides specifically knock down only individual isoforms and do not affect 
levels of the regulatory p85 subunit. GAPDH was used as a loading control. (B) Immunofluorescence micrographs of HUVECs transfected with p110 
or control siRNA. Samples were stained with antibodies to VE-cadherin and PECAM-1 and Alexa Fluor 633–conjugated phalloidin to visualize F-actin. 
The arrow and arrowheads point to examples of linear and overlapping junctions, respectively. Bottom panels are magnifications of the boxed regions 
(merged images), showing detail of overlapping junctions. (C–E) Junctional index (junctional area/cell number; C), cell area (D), and cell circularity (E) 
were determined from immunofluorescence images using ImageJ software. In each case, a minimum of five fields were quantified (20 cells per field) per 
experiment, and data represent the mean and SEM of at least three independent experiments. Statistical significance was assessed by the Mann-Whitney 
U test; *, P < 0.05. Bars, 20 µm.JCB • VOLUME 188 • NUMBER 6 • 2010   866
p110 regulates endothelial permeability
Endothelial permeability is regulated by cell–cell junctions, 
and thus, we investigated whether the effect of p110 deple-
tion  on  junctional  organization  correlated  with  a  change  in 
endothelial  barrier  function.  TNF  treatment  progressively   
increased endothelial permeability to FITC-dextran, with an   
cell (Fig. 2 B; McKenzie and Ridley, 2007). In cells depleted 
of p110, TNF still stimulated an increase in stress fibers, 
although they were no longer aligned in the same direction in 
adjacent cells and thus unlikely to exert tension on junctions 
at the ends of cells (Fig. 2 B). Therefore, a PI3K-independent,   
TNF-stimulated pathway regulates stress fiber assembly.
Figure  2.  Inhibition  of  p110  affects  cell–
cell junctions and cell morphology after TNF- 
mediated  inflammation.  (A)  HUVECs  were   
either stimulated with TNF (10 min to 18 h) 
or  left  unstimulated  before  lysis,  SDS-PAGE, 
and  Western  blotting  with  pAktS473,  Akt, 
and GAPDH antisera. (B) Immunofluorescence   
micrographs  of  HUVECs  transfected  with 
p110 or control siRNA and either stimulated 
with  TNF  (18  h)  or  left  unstimulated  before   
fixation.  Samples  were  stained  with  anti-
bodies to VE-cadherin and PECAM-1 and Alexa 
Fluor 633–conjugated phalloidin to visualize   
F-actin. Bottom panels are magnifications of 
the boxed regions (merged images), showing 
detail of a linear junction (untreated), disrupted 
junctions at the boundary of two elongated 
cells (TNF + si-control), or overlapping junc-
tions (TNF + si-p110). The arrowhead shows 
an  example  of  an  overlapping  junction.   
Bars, 20 µm.867 p110 regulates endothelial barrier function • Cain et al.
affect TEM. Interestingly, p110 depletion induced a small   
reduction in TEM, which could reflect its postulated role in the 
selectin-mediated  tethering  of  leukocytes  to  endothelial  cells 
(Puri et al., 2004). To determine whether PI3Ks also affected 
transcellular TEM, we analyzed diapedesis of T cell lympho-
blasts, which use both paracellular and transcellular pathways 
(Millán et al., 2006). The proportion of T lymphoblasts using the 
paracellular pathway was significantly reduced across p110-
depleted HUVECs, whereas transcellular TEM remained un-
affected, which is consistent with a role for p110 in junctional 
regulation  (Fig.  5  B). Transcellular TEM  represented  around 
15% of TEM events, as previously observed (Millán et al., 2006), 
and was not affected by suppression of any p110 isoform.
To determine which step of leukocyte TEM was affected 
by p110, we used a 3D assay system of HUVECs cultured on 
a thick collagen gel (Fig. 5 C). Depletion of endothelial cell 
p110 did not alter leukocyte adhesion after 10 or 60 min, 
and thus, differences in TEM were not caused by reduced cell   
attachment (Fig. 5, C and D). Indeed, expression of ICAM-1, 
a major leukocyte adhesion receptor up-regulated upon TNF 
stimulation, was not affected by p110 depletion (Fig. S1 A). 
Endothelial ICAM-1 is known to cluster around some adher-
ent  leukocytes  (Barreiro  et  al.,  2002;  Carman  and  Springer, 
2004), but this clustering was not affected by p110 levels   
(Fig. S4, C and D). However, p110 depletion reduced the num-
ber of cells able to transmigrate across the endothelium into 
the collagen gel matrix after 1 h (Fig. 5, C and E). Most adherent 
leukocytes on p110 siRNA–treated HUVECs appeared unable 
approximately twofold increase at 18 h (Fig. 4 A; McKenzie   
and Ridley, 2007). p110 suppression with siRNA strongly reduced 
TNF-induced  endothelial  permeability  (Fig.  4 A),  whereas 
a small decrease was observed for p110 but not p110- or 
p110-depleted cells.
We also used transendothelial resistance (TER) to mea-
sure the intrinsic barrier function of endothelial monolayers. 
The TER of HUVECs treated with TNF was 25% lower than 
unstimulated cells (Fig. 4 B). In agreement with the perme-
ability data, cells depleted of p110 showed a significant   
increase in TER compared with controls (Fig. 4 B), whereas 
knockdown of the other p110 isoforms had no effect. As a 
positive  control, VE-cadherin  depletion  also  reduced  resis-
tance (Fig. 4 B), as previously reported (van Gils et al., 2009). 
In unstimulated cells, p110 depletion also led to an increase 
in TER (Fig. 4 C), correlating with the increase in overlapping 
junctions (Fig. 1 C).
Endothelial p110 regulates leukocyte TEM
Leukocytes can cross the endothelium either through the junc-
tions (paracellular TEM) or through the endothelial cells (trans-
cellular route). Endothelial junctional integrity is known to affect 
leukocyte paracellular TEM (Aghajanian et al., 2008). To assess 
whether PI3K inhibition affected leukocyte TEM, we initially 
measured TEM of THP-1 cells, a monocyte-like cell line which 
only utilizes the paracellular route in vitro (Fig. 5 A and not 
depicted).  There  was  a  significant  reduction  in  THP-1  TEM 
across p110-depleted HUVECs, whereas p110 and - did not   
Figure 3.  Inhibition of p110 increases junctional index, cell area, and cell circularity. (A) Immunofluorescence micrographs of HUVECs transfected with 
p110 or control siRNA and either stimulated with TNF (18 h) or left unstimulated, before fixation. Samples were stained with antibodies to ZO-1 and 
-catenin. Right panels are magnifications of the boxed regions (merged images), showing detail of cell–cell junctions. (B–D) Junctional index (junctional 
area/cell number; B), cell circularity (C), and area (D) were determined from immunofluorescence images using ImageJ software. In each case, a minimum 
of five fields were quantified (20 cells per field) per experiment, and data represent the mean and SEM of at least three independent experiments. Statisti-
cal significance was assessed by the Mann-Whitney U test; *, P < 0.05; **, P < 0.02. Bar, 20 µm.JCB • VOLUME 188 • NUMBER 6 • 2010   868
to cross endothelial junctions, as determined by staining with   
-catenin (unpublished data). For those leukocytes that did cross 
the endothelium, their ability to invade the collagen matrix was 
similar (unpublished data), indicating that p110 depletion in 
endothelial cells does not alter leukocyte migration properties.
p110 inhibition reduces VE-cadherin  
Tyr phosphorylation
Tyr phosphorylation of VE-cadherin is believed to be an impor-
tant factor in regulating vascular permeability and correlates 
with impaired barrier function (Dejana et al., 2008). TNF   
induced VE-cadherin Tyr phosphorylation (Fig. S5 A), which is 
consistent with previous observations (Angelini et al., 2006). 
p110 depletion reduced Tyr phosphorylation of VE-cadherin 
in TNF-stimulated cells (Fig. 6 A). Several Tyr residues in   
the VE-cadherin intracellular domain can be phosphorylated,   
including Y731, Y658, and Y685 (Allingham et al., 2007; 
Wallez et al., 2007; Turowski et al., 2008). To assess whether 
the p110-regulated changes in total VE-cadherin phosphoryla-
tion were caused by one or more of these residues, lysates were 
blotted with phosphospecific antibodies for each of these sites. 
p110 siRNA–treated cells showed a strong reduction in Y731 
phosphorylation and a smaller reduction at Y658 but no change 
at Y685 (Fig. 6 A), indicating that p110 regulates VE-cadherin 
Tyr phosphorylation on specific sites. It is also possible that the 
pY731  antibody  recognizes  other  phospho-Tyr  residues  on   
VE-cadherin in addition to pY731 and that p110 regulates 
phosphorylation of these sites.
p110 depletion reduces Pyk2 activity and 
its association with VE-cadherin
Both  Pyk2  and  Src  have  been  identified  as  potential  Tyr   
kinases involved in the regulation of VE-cadherin phosphory-
lation (Allingham et al., 2007; Turowski et al., 2008). Pyk2   
was present in VE-cadherin immunoprecipitates in unstimulated 
cells and at higher levels in TNF-stimulated cells, whereas its 
close relative FAK was not detected (Fig. 6 B and Fig. S5 A).   
Pyk2  association  with VE-cadherin  was  much  reduced  in 
p110-depleted cells, both in TNF-stimulated and unstimulated 
cells (Fig. 6 B and Fig. S5). In unstimulated cells, knockdown 
of  p110  also  slightly  reduced  Pyk2–VE-cadherin  associa-
tion, suggesting that under some circumstances, p110 could 
also affect junctional integrity, for example downstream of the   
G protein–coupled IL-8 receptor (Gavard et al., 2009), although 
not in the TNF response.
Y402 phosphorylation on Pyk2 reflects Pyk2 kinase activ-
ity (Mitra et al., 2005). TNF induced a small increase in pY402-
Pyk2 at around 60 min and a larger increase at 12–18 h (Fig. 7), 
correlating with the delayed increase in PI3K activity induced 
by TNF (Fig. 2 A). Pyk2 Y402 phosphorylation was reduced by 
p110  suppression  both  in VE-cadherin  immunoprecipitates 
and in total lysates, indicating that p110 regulates both Pyk2 
Figure 4.  Inhibition of p110 increases barrier function in TNF-stimulated 
endothelial cells. (A) p110 siRNA–transfected HUVECs were either TNF-
stimulated  (16–18  h;  A)  or  unstimulated  before  permeability  to  FITC-
  dextran was assessed. (B and C) TNF-stimulated (B) and unstimulated (C), 
p110 siRNA– or VE-cadherin siRNA–transfected HUVECs were seeded 
at confluence in ECIS electrode chambers, and TER was measured (15 V; 
12 h; sampling every 10 min). Data from a stable TER period of 4–6 h 
were used to calculate mean resistance, and comparisons were made with 
unstimulated monolayers (assigned as 100%). Mean change in resistance 
from control is shown. Data represent the mean and SEM of three inde-
pendent experiments performed in triplicate. Statistical significance was 
assessed by the Mann-Whitney U test; *, P < 0.05; **, P < 0.02.
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Figure 5.  p110 inhibition in endothelial cells 
reduces  leukocyte  TEM.  (A)  THP-1  cells  were 
added  to  TNF-stimulated,  siRNA-transfected 
HUVECs  grown  in  Transwell  chambers,  and 
the resultant TEM efficiency toward MCP-1 was 
determined after 1 h. (B) T lymphoblasts were 
added  to  TNF-stimulated,  siRNA-transfected 
HUVECs and fixed after 15 min. Samples were 
analyzed by confocal microscopy and scored 
visually for paracellular and transcellular TEM 
events (Millán et al., 2006). (C) TNF-stimulated, 
p110  siRNA–  or  control  siRNA–transfected 
HUVECs  previously  labeled  with  CellTracker 
orange dye were grown on collagen matrices 
in  Transwell  chambers.  CellTracker  green– 
labeled  THP-1  cells  were  added  to  HUVECs, 
and  TEM  was  allowed  to  proceed  toward 
an MCP-1 gradient in the lower chamber for   
either 10 or 60 min before fixation; confocal   
z stacks were then collected. 3D reconstructions 
were produced using Volocity software. A small 
gamma correction was applied to the red chan-
nel to visualize weak cell tracker staining at the 
edges of cell, which are difficult to distinguish 
upon 3D rendering. (D and E) Quantification   
of  adhesion  to  endothelial  cells  (D)  or  TEM   
(THP-1 cells within the collagen matrix; E). Results 
represent the mean and SEM of at least three   
independent  experiments.  Statistical  signifi-
cance  was assessed by the Mann-Whitney U 
test; *, P < 0.05; **, P < 0.02. Bars, 40 µm.JCB • VOLUME 188 • NUMBER 6 • 2010   870
association with VE-cadherin and Pyk2 activation. Src was also 
detected in VE-cadherin immunoprecipitates, but unlike Pyk2, 
neither its levels nor its activity, as measured with antibodies to 
pY416-Src (Parsons and Parsons, 2004), were affected by p110 
depletion (Fig. 6 B). p110 depletion did not induce reduced 
VE-cadherin binding to all its partners because the levels of   
-catenin  coimmunoprecipitated  with VE-cadherin  were  not   
affected (Fig. 6 and Fig. S5 A).
The p85 subunit of PI3K has previously been reported to 
associate with Tyr phosphorylated VE-cadherin, which could be 
via p85 SH2 domains (Hudry-Clergeon et al., 2005). The level 
of p85 coimmunoprecipitation with VE-cadherin was increased 
by TNF stimulation (Fig. 6 B and Fig. S5 A), reflecting the 
higher VE-cadherin Tyr phosphorylation. The amount of p85 
immunoprecipitated with VE-cadherin was strikingly reduced 
after p110 depletion, both with and without TNF stimulation 
(Fig. 6 B and Fig. S5 A), suggesting that PI3K- activity itself 
regulates  p85  association  with VE-cadherin  by  increasing   
VE-cadherin Tyr phosphorylation.
Knockdown of p110 reduces Rac1 and 
RhoA activity
Rho  GTPases  are  important  regulators  of  endothelial  barrier 
function (Wojciak-Stothard and Ridley, 2002; Fryer and Field, 
2005; Tzima, 2006), and VE-cadherin has been implicated 
in the regulation of Rac1 activity (Lampugnani et al., 2002). 
In addition, PI3K isoforms affect Rho GTPase activity in   
endothelial and other cells (Papakonstanti et al., 2007; Graupera   
et al., 2008; Cain and Ridley, 2009). Therefore, we investi-
gated whether p110 knockdown affected Rho, Rac, or Cdc42   
activity. Despite being implicated in epithelial barrier function 
(Bruewer et al., 2004), active Cdc42 levels were not affected by 
Figure  6.  Inhibition  of  p110  reduces  VE-
  cadherin  Tyr  phosphorylation  and  Pyk2 
activity.  (A  and  B)  TNF-stimulated,  siRNA-
transfected  HUVECs  were  lysed,  and  VE-
  cadherin was immunoprecipitated (i.p.). Samples 
were separated by SDS-PAGE and analyzed by 
Western blotting with antibodies to total phos-
pho-Tyr and for VE-cadherin phosphorylated at 
Y658, Y685, and Y731 (A) and other proteins 
as indicated (B). Total lysates were probed in 
parallel (blots on right) to control for variations 
in protein level.871 p110 regulates endothelial barrier function • Cain et al.
permeability and leukocyte TEM. Our results indicate that p110 
acts via VE-cadherin Tyr phosphorylation, the Tyr kinase Pyk2, 
and the Rho GTPase Rac1 to regulate these responses.
Tyr  phosphorylation  of  the  intracellular  domain  of 
VE-cadherin leads to protein binding and correlates with in-
creased endothelial permeability and TEM (Lambeng et al.,   
2005; Potter et al., 2005; Turowski et al., 2008). Our data   
indicate that p110 plays a key role in the assembly of a   
VE-cadherin signaling complex by regulating Tyr phosphory-
lation of VE-cadherin residue Y731, with a smaller effect on   
Y658. Several kinases contribute to VE-cadherin phosphoryla-
tion, including Pyk2 and Src family kinases, and a dominant- 
negative Pyk2 construct was shown to affect junctional integrity 
(Weis et al., 2004; van Buul et al., 2005; Allingham et al., 
2007; Wallez et al., 2007). In agreement with this, we find 
that knockdown of Pyk2 reduces both endothelial permeabil-
ity and leukocyte TEM. We show in this study for the first time 
that p110 acts upstream of Pyk2 and regulates both Pyk2 
autophosphorylation  and  its  association  with  VE-cadherin. 
Like its close relative FAK, Pyk2 autophosphorylation recruits 
Src kinases (Basile et al., 2007). VE-cadherin Y731 is a puta-
tive Pyk2 target (Dejana et al., 2008), although it is unclear 
whether Pyk2 is able to directly phosphorylate VE-cadherin 
in vivo or whether it acts indirectly, for example by recruiting 
a Src kinase such as Fyn, which has been reported to mediate 
TNF-induced Tyr phosphorylation of VE-cadherin (Angelini 
et al., 2006). As Pyk2 has no SH2 domain, it is unlikely to bind   
directly to phosphorylated tyrosines in VE-cadherin, but it 
could be recruited via the p85 regulatory subunit of PI3K. We 
show that p85 associates with VE-cadherin and PI3K interacts 
with Pyk2 (Melikova et al., 2004), probably via the inter-
action of a p85 SH2 domain with a Pyk2 phospho-Tyr (van Buul   
et al., 2005; Allingham et al., 2007). Interestingly, p85 inter-
action with VE-cadherin is reduced by p110 inhibition, pre-
sumably because p85 association with the complex depends 
on PI3K-–mediated VE-cadherin Tyr phosphorylation.
Our data suggest that p110 regulates Rac activity via   
recruitment of the Rac GEF Tiam-1 to the VE-cadherin com-
plex. Recruitment of Tiam-1 to membranes in endothelial 
cells is dependent on VE-cadherin (Lampugnani et al., 2002), 
and the N-terminal pleckstrin homology domain of Tiam-1 
p110 knockdown (Fig. 8 A). In contrast, Rac1 and RhoA activi-
ties were both dramatically reduced in p110-depleted HUVECs 
but not by knockdown of the other PI3K isoforms. Interestingly, 
of the Rho isoforms, only the level of GTP-RhoA was affected 
by p110 but not GTP-RhoB or -RhoC (Fig. 8 B).
VE-cadherin regulates the localization of the Rac guanine 
nucleotide exchange factor (GEF) Tiam-1 to endothelial cell–
cell junctions (Lampugnani et al., 2002), and PI3Ks regulate 
Tiam-1 localization through its N-terminal pleckstrin homology 
domain (Sander et al., 1998). To assess whether PI3K-mediated 
changes in Rac1 or RhoA activity were linked to VE-cadherin, 
VE-cadherin immunoprecipitates from p110-depleted HUVECs 
were probed for the Rac GEFs Tiam-1 and Vav and the Rho 
GEF GEF-H1, which has previously been reported to localize to 
endothelial junctions (McKenzie and Ridley, 2007). Although 
Vav and GEF-H1 could not be detected (not depicted), Tiam-1 
associated with VE-cadherin in both unstimulated and TNF-
stimulated endothelial cells, and levels were lower in p110-
depleted HUVECs (Fig. 8 C and Fig. S5). This suggests that 
p110 mediates Rac1 activation by regulating Tiam-1 associa-
tion with VE-cadherin.
Rac1 and Pyk2 regulate endothelial barrier 
function and leukocyte TEM
Because p110 regulates both Rac1 and Pyk2 activities, we 
investigated whether they contributed to p110-regulated bar-
rier function in endothelial cells using siRNA to knock down 
their expression (Fig. 9 A). Both Pyk2 and Rac1 depletion 
reduced  TNF-induced  endothelial  permeability  (Fig.  9  B),   
whereas RhoA knockdown had no effect (Fig. S5). In addition, 
knockdown of Pyk2 or Rac1 in HUVECs reduced THP-1 TEM, 
and this effect was significant when both Pyk2 and Rac1 were 
depleted (Fig. 9 D). Interestingly, Pyk2 and Rac1 each had 
different effects on endothelial morphology that could affect 
barrier function. Like p110 suppression, Pyk2-depleted cells 
had an increase in overlapping cell junctions and junctional   
index, both in stimulated and unstimulated cells, whereas Rac1 
knockdown did not affect junctional index (Fig. 9 E and not 
depicted). In contrast, Rac1 and p110 but not Pyk2 depletion 
inhibited TNF-induced cell elongation (circularity; Fig. 9, C 
and F), which reduced the disruption of junctions observed   
at the ends of elongated cells (Fig. 2 B). Knockdown of both   
Rac1 and Pyk2 inhibited cell elongation and increased over-
lapping junctions (Fig. 9, E and F), although stress fibers were 
still induced, which is consistent with results with p110   
depletion (Fig. 2 B). These results indicate for the first time 
that TNF-induced changes to cell shape and junction morphol-
ogy are regulated separately and that both of these responses 
are likely to affect barrier function.
Discussion
PI3Ks have been shown to regulate vascular integrity and angio-
genesis during development, but the mechanistic basis for their 
effects on endothelial cells has not been determined. In this study, 
we have identified a specific role for p110 in regulating   
endothelial junctions, affecting both TNF-induced endothelial 
Figure 7.  Pyk2 activity is increased by TNF stimulation. Endothelial cells 
were either stimulated with TNF (10 min to 18 h) or left unstimulated be-
fore lysis, SDS-PAGE, and immunoblotting with pY402-Pyk2, Pyk2, and 
GAPDH antisera.JCB • VOLUME 188 • NUMBER 6 • 2010   872
binds to PtdIns(3,4,5)P3 (Hordijk et al., 1997; Michiels et al., 
1997). Association of p110 via p85 with VE-cadherin might   
thereby provide a mechanism by which Tiam-1 is recruited 
and activates Rac1.
p110  inhibition  prevents  two  TNF-induced  morpho-
logical responses that could be linked to endothelial barrier 
function, cell junction morphology, and cell elongation via 
Pyk2  and  Rac1,  respectively.  p110  and  Pyk2  depletion   
both lead to an increase in adherens junction staining, pre-
dominantly in regions where endothelial cells overlap. These 
junction-rich regions are likely to form a strong barrier to both 
small  molecules  and  leukocytes.  In  contrast,  Rac1  mediates 
TNF-induced elongation and contributes to permeability and 
leukocyte TEM, indicating that cell shape affects barrier func-
tion. This could be because in elongated cells, stress fibers   
exert a higher tension on cell–cell junctions and thus decrease 
junctional integrity at cell poles compared with cells with a 
more  cobblestone  shape.  Indeed,  leukocytes  preferentially 
transmigrate at poles of elongated endothelial cells (Millán   
et al., 2006), and endothelial shape changes have been pro-
posed to contribute to TNF-induced vascular leakage in vivo 
(Cotran and Pober, 1990). Interestingly, RhoA-depleted cells   
did  not  show  a  reduction  in TNF-induced  stress  fibers  or   
altered barrier function. This is consistent with our previous   
results suggesting that TNF-induced stress fiber assembly and 
endothelial permeability do not correlate with RhoA activa-
tion (McKenzie and Ridley, 2007).
Previous studies have suggested that PI3Ks are important 
for efficient TEM in vivo and in vitro (Puri et al., 2004, 2005; 
Nakhaei-Nejad et al., 2007). In vitro, treatment of HUVECs 
with pan-PI3K inhibitors did not affect lymphocyte adhesion 
but  reduced  diapedesis.  Our  results  indicate  that  this  step   
specifically involves p110. In vivo studies with gene-targeted 
mice have implicated endothelial p110 and - in selectin- 
mediated  neutrophil  tethering  and  rolling  but  not  ICAM-1– 
mediated  firm  attachment  to  endothelial  cells  (Puri  et  al., 
2004, 2005), and indeed, we see a small effect of p110 on 
leukocyte TEM in our model, which is consistent with an   
involvement in selectin function. So far, the roles of p110 
or - have not been tested in vivo. Collectively, these results 
and our data indicate that p110 acts in endothelial cells pri-
marily to regulate changes in junctional integrity induced by 
TNF and thus influence leukocyte diapedesis, whereas p110  
and - are involved in selectin-mediated leukocyte tethering. 
It is also possible that p110 affects adhesion receptor signal-
ing in some way that reduces subsequent TEM.
In conclusion, we have shown that the p110 isoform of 
PI3K specifically regulates cell–cell contacts in endothelial 
cells, thereby contributing to TNF-induced changes to endo-
thelial barrier function and leukocyte TEM. This selective 
Figure 8.  p110 depletion decreases RhoA and Rac but not Cdc42 activity. 
(A and B) TNF-stimulated, p110 siRNA–transfected HUVECs were lysed, 
and Rho GTPase activity was determined by affinity for GST-Rhotekin-RBD– or 
GST-PAK1-PBD–conjugated beads for RhoA/B/C and Rac/Cdc42, respec-
tively. After washing, samples were separated by SDS-PAGE and analyzed 
by Western blotting with antibodies to Rac1 or Cdc42 (A) or RhoA, -B, or 
-C (B). Total lysates (bottom) of each sample were Western blotted in paral-
lel to control for total amounts of GTPase. GAPDH was used as a loading 
control. (C) PI3K inhibition reduces Tiam-1 association with VE-cadherin. 
TNF-stimulated, siRNA-transfected HUVECs were lysed, and VE-cadherin 
was  immunoprecipitated  (i.p.).  Samples  were  separated  by  SDS-PAGE 
and analyzed by Western blotting with antibodies to Tiam-1. Total lysates 
(bottom) were probed in parallel to control for variations in protein level. 
GAPDH was used as a loading control.
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Materials and methods
Antibodies and reagents
Antibodies to p110, -, -, and - have been previously described   
(Graupera et al., 2008; Guillermet-Guibert et al., 2008). Antibodies to 
ZO-1, -2, and -3, JAM-A, occludin, VE-cadherin–Y731, and claudin-5 
were purchased from Invitrogen, - and -catenin and -actin were   
role of p110 in endothelial cells could in part explain its role 
to angiogenesis (Graupera et al., 2008), which requires dy-
namic changes to endothelial cell–cell junctions and shape. 
Our results suggest that p110-selective inhibitors could be 
used to treat chronic inflammatory diseases involving TNF 
such as arthritis and atherosclerosis.
Figure  9.  Pyk2  and  Rac1  depletion  alter 
endothelial  junctions  and  leukocyte  TEM. 
HUVECs were transfected with either control 
siRNA  or  siRNA  to  Pyk2  and/or  Rac1  and 
then stimulated with TNF (18 h) or left unstimu-
lated. (A) HUVECs were lysed and analyzed   
by  SDS-PAGE  and  Western  blotting  with   
Pyk2, Rac1, and GAPDH antibodies to assess 
siRNA knockdown efficiency and ICAM-1 to 
assess TNF stimulation. The asterisk indicates   
a nonspecific band; Rac1 is the top band. 
(B) Barrier function of siRNA-treated HUVECs   
either stimulated with TNF (16–18 h) or left 
unstimulated was assessed by permeability to 
FITC-dextran.  Unstimulated  monolayers  were 
assigned as 100%. (C) Immunofluorescence mi-
crographs of siRNA-transfected HUVECs. Sam-
ples were stained with antibodies to VE-cadherin 
and Alexa Fluor 633–conjugated phalloidin to 
visualize F-actin. Arrowheads indicate exam-
ples of overlapping junctions. (D) THP-1 cells 
were added to siRNA-treated, TNF-stimulated   
HUVECs in Transwell chambers, and the resultant 
TEM efficiency toward MCP-1 was determined 
after 1 h. (E and F) Junctional index (junctional 
area/cell number; E) and cell circularity (F) 
were determined from immunofluorescence im-
ages. Data represent the mean and SEM of at 
least four independent experiments, each per-
formed in triplicate. Statistical significance was 
assessed by the Mann-Whitney U test; *, P < 
0.05; **, P < 0.02. Bars, 20 µm.JCB • VOLUME 188 • NUMBER 6 • 2010   874
software analysis options (Fig. S2 B). In each case, a minimum of five fields 
were quantified (20 cells per field) per experiment, and data shown   
represent the mean of at least three independent experiments.
TEM assay
HUVECs were plated at confluence on Transwell inserts (5-µm pore). After 
6–8 h, cells were treated with 10 ng/ml TNF for 18 h. 10 µg/ml MCP-1 
was added to the bottom chamber before the addition of 1 × 10
5 washed 
THP-1 cells to the upper chamber. Cells were left to transmigrate (1 h; 
37°C) before medium from the bottom chamber was removed, and cells 
were counted using a cell counter (CASY; Innovatis). Each experiment was 
performed in triplicate. For quantification of T lymphoblast paracellular and 
transcellular TEM events, T lymphoblasts (provided by E. Cernuda-Morollon, 
University College London, London, England, UK) were added to conflu-
ent TNF-stimulated HUVECs on glass coverslips for 15 min before fixation 
with 4% paraformaldehyde. Samples were stained with anti–ICAM-1/
Alexa  Fluor  488–conjugated  anti–mouse  IgG,  anti–-catenin/Alexa 
Fluor  546–conjugated  anti–rabbit,  and  Alexa  Fluor  633–conjugated   
phalloidin. T lymphoblasts undergoing TEM were easily distinguishable by 
confocal microscopy, as the leading edge was in contact with the cover-
slip, whereas the rear uropod was still localized on the surface of the   
endothelial cell. -Catenin and ICAM-1 staining was used to determine 
whether the cell was undergoing paracellular or transcellular diapedesis, 
respectively. Each experiment was performed in quadruplicate, quantify-
ing 25 fields per condition.
3D model for TEM
HUVECs were seeded at confluence onto collagen I gels polymerized in 
12-µm pore Transwell filters. After 6–8 h, monolayers were treated with 
10 ng/ml TNF for 18 h. HUVECs were labeled with 5 µM CellTracker 
orange for 40 min before washing in normal medium. 10 µg/ml MCP-1 
was added to the bottom chamber before the addition of 1 × 10
4 washed 
CellTracker green–labeled THP-1 cells to the upper chamber. After 10 or 
60 min, HUVECs were washed three times to remove unbound THP-1 cells, 
and then Transwells were fixed by immersion in 3.7% (wt/vol) parafor-
maldehyde before being processed for immunofluorescence microscopy. 
z  sections  were  acquired  at  200-nm  intervals  by  confocal  microscopy 
(see Immunofluorescence microscopy), and 3D images were reconstructed   
using Volocity image analysis software (PerkinElmer). Adhesion and TEM 
(leukocytes below the level of the endothelial cells) were assessed using   
ImageJ software to count CellTracker green voxols either above or within 
the matrix, and cell numbers were determined by comparison with a   
standard curve of known voxol/cell numbers.
Transendothelial permeability assays
HUVECs were seeded onto 0.4-µm pore Transwell filters (Thermo Fisher 
Scientific)  at  confluency.  After  6–8  h,  monolayers  were  treated  with   
10  ng/ml  TNF  for  18  h.  0.1  µg/ml  FITC-dextran  (molecular  weight, 
42,000) was subsequently applied to the apical chamber and allowed 
to equilibrate for 45 min before a sample of the medium was removed 
from  the  lower  chamber  to  measure  basal  permeability.  Fluorescence 
was measured using a fusion universal microplate analyzer (Fusion-FA; 
PerkinElmer; excitation, 492 nm; detection, 520 nm), and data were 
expressed as a ratio of the control untreated monolayer fluorescence. All 
experiments were performed in triplicate, and results shown are the mean 
of at least four independent experiments.
TER measurement
Transfected HUVECs were plated at confluence on dishes containing gold 
electrodes (ECIS; Applied Biophysics). After 24 h, cells were washed in 
warm EGM-2 media and either treated with 10 ng/ml TNF for 18 h or left 
untreated before data were collected on a resistance meter (ECIS 1600; 
Applied Biophysics). Resistance data were collected at a constant voltage 
of 15 V for a period of 12 h, sampling data every 10 min. Data from a   
stable period of 4–6 h were used to calculate mean resistance. Control 
siRNA transfection did not alter the TNF-induced decrease in resistance.
Rho, Rac, and Cdc42 activity assays
Pull-down activity assays were performed using either GST-Rhotekin RBD 
beads (Cytoskeleton, Inc.; 50 µg per pull-down for Rho) or GST-PAK1 
PBD agarose conjugate (Millipore; 10 µg per pull-down for Rac/Cdc42). 
7 × 10
6 cells per condition were lysed rapidly in pull-down buffer (50 mM 
Tris, pH 7.5, 1% Triton X-100, 0.5% Na deoxycholate, 0.1% SDS, 500 mM   
NaCl, 100 mM MgCl2, 10 µg/ml leupeptin, 10 µg/ml aprotinin, 1 mM PMSF, 
10% glycerol, and 1 mM DTT) before transferring to a microfuge tube 
(Fresco 17 centrifuge; Thermo Fisher Scientific) and centrifuging (13,000 g;   
purchased from Sigma-Aldrich; VE-cadherin, p120-catenin, and phospho–
p120-catenin were obtained from BD; RhoA, -B, and -C and Tiam-1 were 
purchased from Santa Cruz Biotechnology, Inc.; Akt, pAktS473, pAktT308, 
Pyk2, and Pyk2Y402 were obtained from Cell Signaling Technology; VE-
cadherin–Y658, glyceraldehyde 3-phosphate dehydrogenase (GAPDH), 
and p85 were obtained from Millipore; VE-cadherin–Y685 was purchased 
from  ECM  Biosciences;  ICAM-1  was  obtained  from  R&D  systems;  and 
PECAM-1  was  obtained  from  Dako.  FITC-dextran  was  purchased  from 
Sigma-Aldrich, and TNF was obtained from PeproTech. CellTracker orange 
and CellTracker green dyes were purchased from Invitrogen.
Cell culture
Pooled HUVECs were purchased from Lonza and cultured in EGM-2 me-
dium (Lonza) containing 3% FCS. Cells were used for experiments between 
passages 1 and 4 and were seeded onto fibronectin-coated (10 µg/ml; 
Sigma-Aldrich) flasks, glass coverslips, or filters. For experiments, HUVECs 
were stimulated with 10 ng/ml TNF for 18 h except where indicated. THP-1   
cells were maintained in suspension culture in RPMI 1640 medium (Invitro-
gen) containing 10% FCS and 2 mM l-Gln at between 5 × 10
5 and 2 × 
10
6/ml. T lymphoblasts were prepared from isolated human peripheral 
blood mononuclear cells (peripheral blood lymphocytes). After stimula-
tion with 0.5% phytohemagglutinin for 48 h, nonadherent peripheral 
blood lymphocytes were washed and cultured in RPMI 1640 medium   
(10% FCS and 2 U/ml IL-2 in 5% CO2) and used in experiments after   
culturing for 7–12 d.
siRNA transfection
HUVECs were seeded at 10
5 cells per well in 6-well dishes 24 h before 
transfection. Four individual siRNA oligonucleotides (Thermo Fisher Scien-
tific) targeting each of the human p110 (D-003018-05, D-003018-06, 
D-003018-07, and D-003018-08), p110 (D-003019-05, D-003019-06, 
D-003019-07, and D-003019-09), p110 (D-005274-03, D-005274-04,   
D-005274-05, and D-005274-06), or p110 (D-006775-05, D-006775-
06, D-006775-07, and D-006775-08) catalytic subunits or oligonucleotides 
targeting RhoA (D-003860-01 and D-003860-03), Rac1 (D-003560-05 
and D-003560-07), Pyk2 (L-003165-00), or VE-cadherin (D-003641-03) 
were tested for knockdown activity by Western blotting and subsequently 
used individually (RhoA, Rac1, Pyk2, and VE-cadherin) or as four oligo-
nucleotide pools. For p110 isoforms, the siRNA pools gave the strongest 
knockdown and were therefore used in all subsequent experiments. siRNAs 
diluted in EBM-2 medium without FCS were premixed with EBM-2–diluted 
Oligofectamine  reagent  (Invitrogen)  as  described  in  the  manufacturer’s   
instructions. Cells were transfected (6 h) in 1 ml of EBM-2 medium contain-
ing growth supplements, but excluding antibiotics and FCS, giving a final 
oligonucleotide concentration of between 80 and 200 nM. 1 ml EBM-2 
medium with growth factors and 8% FCS was subsequently added to each 
well, and cells were incubated overnight. After transfection (24 h), cells 
were trypsinized and plated either at confluence or subconfluence and 
allowed to adhere (8 h) on fibronectin-coated dishes or coverslips for the 
different assays.
Immunofluorescence microscopy
HUVECs grown to confluence on glass coverslips were fixed with 3.7% 
(wt/vol)  paraformaldehyde,  permeabilized  with  0.2%  (vol/vol)  Triton   
X-100 in PBS (15 min), blocked with 3% (wt/vol) BSA in PBS (1 h), and 
then incubated with primary antibodies in 3% BSA in PBS (1 h). Samples 
were sequentially incubated for 1 h with Alexa Fluor 488– or Alexa Fluor 
546–conjugated anti–rabbit or anti–mouse IgG secondary antibodies, fol-
lowed by incubation with Alexa Fluor 633–conjugated phalloidin (20 min; 
Invitrogen). Coverslips were mounted using ProLong Antifade reagent (Invi-
trogen).  Images  were  acquired  at  room  temperature  using  a  confocal   
microscope (LSM 510 META; Carl Zeiss, Inc.) with three single photomulti-
plier tube confocal detectors mounted on an inverted microscope (Axio-
Observer Z1; Carl Zeiss, Inc.) at a magnification of 40 with an oil immersion 
objective  (EC  Plan-Neofluar  40×  NA  1.30  oil  differential  interference   
contrast M27). Images were processed using Zen software (Carl Zeiss, 
Inc.), and figures were assembled using Photoshop CS4 (Adobe). Quantifi-
cation of cell area, circularity, and junctional index (junctional area/cell 
number)  was  performed  using  ImageJ  software  (National  Institutes  of 
Health). Circularity was calculated using the formula 4(area/perimeter
2). 
A circularity value of 1 indicates a perfect circle. As the value approaches 
0, it indicates an increasingly elongated polygon. Junctional index was 
calculated  using  the  formula  ([junctional  area/total  area]  ×  100)/cell   
number. Junctional area was calculated per field by using the VE-cadherin–
stained channel, thresholding the image to create an even intensity stain 
corresponding to junctional area, and quantifying its area using the   875 p110 regulates endothelial barrier function • Cain et al.
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10 min; 4°C). A 50-µl sample of whole cell lysate was retained, and   
the remaining supernatant was incubated with the appropriate beads   
(1 h; 4°C with rotation). Beads were washed three times in pull-down 
buffer  and  boiled  for  5  min  in  Laemmli  sample  buffer,  and  proteins   
were  resolved  by  SDS-PAGE  and  Western  blotting.  Protein  loading   
was determined by reprobing the whole cell lysate lanes with an anti-
GAPDH antibody.
Immunoprecipitation and Western blotting
HUVECs were harvested by scraping into lysis buffer (50 mM Tris-HCl,   
pH 7.4, 1% [vol/vol] NP-40, 150 mM NaCl, 0.25% Na deoxycholate,   
1 mM EGTA, 1 mM Na orthovanadate, 1 mM Na fluoride, 1 µM PMSF,   
and 1 µg/ml each of aprotinin, leupeptin, and pepstatin) and lysed by 
passing through a 21-gauge needle. Lysates were clarified (10,000 g;   
10 min; 4°C), and protein concentrations were measured and standard-
ized.  VE-cadherin  was  immunoprecipitated  by  the  addition  of  anti– 
VE-cadherin monoclonal antibodies and protein G–conjugated agarose 
beads (2 h; 4°C). A sample of identically treated control lysates was incu-
bated with agarose-conjugated anti–mouse IgG as a negative antibody 
control. Beads were sedimented (500 g; 1 min) and washed three times 
with lysis buffer containing an additional 100 mM NaCl. Immunoprecipi-
tated proteins were eluted and boiled in Laemmli buffer containing 0.1 mM 
DTT. Samples were separated by SDS-PAGE using a gradient gel system 
(12–15% gradient gels; Invitrogen), transferred to polyvinylidene fluoride 
membranes (2 h; 50 V), and blocked with 5% nonfat dried milk or 5% BSA 
in TBS (20 mM Tris-HCl, pH 7.5, and 150 mM NaCl), followed by subse-
quent incubations with appropriate primary and secondary antibodies in 
TBS with 5% nonfat dried milk/BSA (1 h or overnight) and washing in   
TBS-T  (TBS  with  0.1%  Triton  X-100).  Proteins  were  detected  using  the   
enhanced chemiluminescence detection system (GE Healthcare).
Online supplemental material
Fig. S1 shows the knockdown efficiency of p110 isoforms and effects on 
Akt phosphorylation. Fig. S2 shows that depletion of p110, -, or - does 
not affect endothelial junctions or morphology. Fig. S3 shows that depletion 
of p110 isoforms does not affect the expression of junctional proteins or 
TNF-induced p38MAPK activation. Fig. S4 shows that depletion of p110, 
-, or - does not affect junctional organization or ICAM-1 clustering in 
TNF-stimulated cells. Fig. S5 shows the effects of p110, Rac1, and RhoA 
depletion on endothelial junctions. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.200907135/DC1.
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